Millipore Sigma Vibrant Logo

MAB19562 Anti-Laminin-5 (γ2 chain) Antibody, clone D4B5

View Products on Sigmaaldrich.com
MAB19562
100 µg  
Retrieving price...
Price could not be retrieved
Minimum Quantity is a multiple of
Maximum Quantity is
Upon Order Completion More Information
You Saved ()
 
Request Pricing
Limited Availability
Limited Availability
In Stock 
Discontinued
Limited Quantities Available
Availability to be confirmed
    Remaining : Will advise
      Remaining : Will advise
      Will advise
      Contact Customer Service
      Contact Customer Service

      Special Offers

       

      Contact Customer Service

      Overview

      Replacement Information

      Key Spec Table

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HELISA, IH(P), WBMPurifiedMonoclonal Antibody
      Description
      Catalogue NumberMAB19562
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Laminin-5 (γ2 chain) Antibody, clone D4B5
      Alternate Names
      • Laminin 5
      Background InformationLaminins are basement membrane, extracellular matrix glycoproteins that are composed of alpha, beta and gamma heterotrimeric chains. Different combinations of five alpha chains, three beta chains, and two gamma chains form at least 12 laminin isoforms. Laminin-5 (LN5), which consists of laminin alpha3, beta3 and gamma2 chains, is a highly conserved component of anchoring filaments underlying the hemidesmosome structure of epidermal keratinocytes. Mutations or deletion in the LN5 genes (LAMA3, LAMB3, and LAMC2) is associated with epidermolysis bullosa, a lethal skin blistering disease. LN5 may stabilize the epidermal/dermal junction of skin through binding with integrins alpha3/beta1, alpha6/beta4 and type VII collagen and has a critical role in the anchorage and locomotion of a wide variety of cell types, including epithelial cells, fibroblasts, neurons and leukocytes. Compared to fibronectin, collagen, or vitronectin, cells of epithelial origin will adhere to Laminin-5 faster and will spread to a larger extent. Recently, Laminin-5 is attracting attention as a substrate for carcinoma cells that may stimulate migration, since it has been detected at the leading edge of invasive cancer tissue in several types of human carcinomas (Niki, et al., 2002, Lohi, et al., 2001).
      References
      Product Information
      FormatPurified
      HS Code3002 15 90
      Control
      • Human pancreatic tumor tissue, human breast carcinoma tissue or A-431 whole cell lysate
      PresentationProtein A Purified mouse immunoglobulin in 20 mM sodium phosphate, 250 mM NaCl, pH. 7.6, with 0.1% sodium azide as a preservative.
      Quality LevelMQ100
      Applications
      ApplicationAnti-Laminin-5 (γ2 chain) Antibody, clone D4B5 is an antibody against Laminin-5 (γ2 chain) for use in ELISA, IH(P) & WB.
      Key Applications
      • ELISA
      • Immunohistochemistry (Paraffin)
      • Western Blotting
      Application NotesWestern blot: 5ug/ml is recommended; dilute antibody in PBS or TBS only, not blocking solutions; blocking with purified compounds is suggested.

      Immunohistochemistry of paraffin sections: 5-10ug/ml is suggested. Do not over fix. A light 4% or 2% PFA are best. 4 mm thick paraffin sections are dewaxed, rehydrated and immersed in 0.3% hydrogen peroxide-containing methanol for inactivation of intrinsic peroxidase, followed by treatment with Protease XXIV (Sigma) for 15 min at room temperature (0.01-0.05%). Do not use trypsin. Antibody incubation at 37°C for 1 hour, followed by secondary antibody detection and visualization with DAB (Mizushima et al. 1998). Do not place the monoclonal antibody in serum blocks because serum conatins laminin 5 which will bind and interfere with the antibody. Use BSA or other such media instead.

      Strongly positive staining is seen in Basement Membrane of the following tissues: Skin, Esophagus, Lung, and Kidney. Positive staining is also seen in Stomach, Small intestine, Spleen, Thymus, Prostate, and Ovary. Thyroid, Testis, Skeletal and Cardiac muscle were negative for LN5 staining.

      Inhibition of alpha2beta1 integrin binding to laminin 5 (40ug/ml) (Decline & Rousselle 2000).

      ELISA Optimal working dilutions must be determined by end user.
      Biological Information
      ImmunogenAmino acid residues 382-608 of human laminin-5 gamma2 chain (III domain) expressed as a GST fusion protein
      CloneD4B5
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      SpecificityMonoclonal antibody MAB19562 was developed against amino acid residues 382-608 of human laminin-5 gamma2 chain (III domain) expressed as a GST fusion protein. The antibody recognizes the 150 (precursor form) and 105 kDa (mature form) chain proteins of Laminin-5. No reactivity is expected with other laminin types, as the gamma2 chain of laminin is unique to laminin-5.
      IsotypeIgG1
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Entrez Gene Number
      Gene Symbol
      • LAMC2
      • EBR2
      • LAMB2T
      • MGC141938
      • MGC138491
      • LAMNB2
      • epiligrin
      • BM600-100kDa
      • BM600
      • kalinin-105kDa
      • nicein-100kDa
      • EBR2A
      • B2T
      • CSF
      Purification MethodProtein A Purfied
      UniProt Number
      UniProt SummaryFUNCTION: SwissProt: Q13753 # Binding to cells via a high affinity receptor, laminin is thought to mediate the attachment, migration and organization of cells into tissues during embryonic development by interacting with other extracellular matrix components. Ladsin exerts cell- scattering activity toward a wide variety of cells, including epithelial, endothelial, and fibroblastic cells.
      SIZE: 1193 amino acids; 130976 Da
      SUBUNIT: Laminin is a complex glycoprotein, consisting of three different polypeptide chains (alpha, beta, gamma), which are bound to each other by disulfide bonds into a cross-shaped molecule comprising one long and three short arms with globules at each end. Gamma-2 is a subunit of laminin-5 (epiligrin/kalinin/nicein).
      SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix, basement membrane. Note=Major component.
      TISSUE SPECIFICITY: The large variant is expressed only in specific epithelial cells of embryonic and neonatal tissues. In 17-week old embryo the small variant is found in cerebral cortex, lung, and distal tubes of kidney, but not in epithelia except for distal tubuli.DOMAIN:SwissProt: Q13753 The alpha-helical domains I and II are thought to interact with other laminin chains to form a coiled coil structure. & Domain IV is globular.
      DISEASE: SwissProt: Q13753 # Defects in LAMC2 are a cause of junctional epidermolysis bullosa gravis (JEB) [MIM:226700]; also known as junctional epidermolysis bullosa Herlitz-Pearson type. JEB is a blistering disorder in skin that is characterized by a separation of basal cells from the basement membrane due to a decreased number of hemidesmosomes. Laminin-5 is missing from the basement membrane of patients with the gravis form of epidermolysis bullosa.
      SIMILARITY: Contains 8 laminin EGF-like domains. & Contains 1 laminin IV type A domain.
      MISCELLANEOUS: Binds heparin (By similarity).
      Molecular Weight150 kDa (precursor form) and 105 kDa (mature form)
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Quality AssuranceEvaluated by Western Blot on recombinant Laminin-5.

      Western Blot Analysis: A 1:500-1:2000 dilution of this antibody detected Laminin-5, gamma2 chain in 10 µg of human recombinant Laminin-5.
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain for 1 year at 2–8°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
      Packaging Information
      Material Size100 µg
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Catalogue Number GTIN
      MAB19562 08436037124709

      Documentation

      Anti-Laminin-5 (γ2 chain) Antibody, clone D4B5 SDS

      Title

      Safety Data Sheet (SDS) 

      Anti-Laminin-5 (γ2 chain) Antibody, clone D4B5 Certificates of Analysis

      TitleLot Number
      Anti-Laminin 2, clone D4B5 - JBC1868686 JBC1868686
      Anti-Laminin 2, clone D4B5 - LV1657463 LV1657463
      Anti-Laminin 2, clone D4B5 - LV1739277 LV1739277
      Anti-Laminin 2, clone D4B5 - LV1785828 LV1785828
      Anti-Laminin 2, clone D4B5 - NG1668240 NG1668240
      Anti-Laminin y2, clone D4B5 - LV1473020 LV1473020
      Anti-Laminin y2, clone D4B5 - LV1597162 LV1597162
      Anti-Laminin-5 (2 chain), clone D4B5 - 1976914 1976914
      Anti-Laminin-5 (2 chain), clone D4B5 - 2000810 2000810
      Anti-Laminin-5 (2 chain), clone D4B5 - 2034706 2034706

      References

      Reference overviewApplicationSpeciesPub Med ID
      Biological Effects Induced by Specific Advanced Glycation End Products in the Reconstructed Skin Model of Aging.
      Pageon, H; Zucchi, H; Dai, Z; Sell, DR; Strauch, CM; Monnier, VM; Asselineau, D
      BioResearch open access  4  54-64  2015

      Show Abstract
      26309782 26309782
      Lysyl Hydroxylase 3 Localizes to Epidermal Basement Membrane and Is Reduced in Patients with Recessive Dystrophic Epidermolysis Bullosa.
      Watt, SA; Dayal, JH; Wright, S; Riddle, M; Pourreyron, C; McMillan, JR; Kimble, RM; Prisco, M; Gartner, U; Warbrick, E; McLean, WH; Leigh, IM; McGrath, JA; Salas-Alanis, JC; Tolar, J; South, AP
      PloS one  10  e0137639  2015

      Show Abstract
      26380979 26380979
      Type VII collagen regulates expression of OATP1B3, promotes front-to-rear polarity and increases structural organisation in 3D spheroid cultures of RDEB tumour keratinocytes.
      Dayal, JH; Cole, CL; Pourreyron, C; Watt, SA; Lim, YZ; Salas-Alanis, JC; Murrell, DF; McGrath, JA; Stieger, B; Jahoda, C; Leigh, IM; South, AP
      Journal of cell science  127  740-51  2014

      Show Abstract
      24357722 24357722
      A simple alkaline method for decellularizing human amniotic membrane for cell culture.
      Saghizadeh, M; Winkler, MA; Kramerov, AA; Hemmati, DM; Ghiam, CA; Dimitrijevich, SD; Sareen, D; Ornelas, L; Ghiasi, H; Brunken, WJ; Maguen, E; Rabinowitz, YS; Svendsen, CN; Jirsova, K; Ljubimov, AV
      PloS one  8  e79632  2013

      Show Abstract
      24236148 24236148
      Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin-integrin signalling in head and neck squamous cell carcinoma.
      Kinoshita, T; Nohata, N; Hanazawa, T; Kikkawa, N; Yamamoto, N; Yoshino, H; Itesako, T; Enokida, H; Nakagawa, M; Okamoto, Y; Seki, N
      British journal of cancer  109  2636-45  2013

      Show Abstract
      24091622 24091622
      IκB kinase complex (IKK) triggers detachment-induced autophagy in mammary epithelial cells independently of the PI3K-AKT-MTORC1 pathway.
      Chen, N; Debnath, J
      Autophagy  9  1214-27  2013

      Show Abstract
      23778976 23778976
      p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model.
      Olsen, JR; Oyan, AM; Rostad, K; Hellem, MR; Liu, J; Li, L; Micklem, DR; Haugen, H; Lorens, JB; Rotter, V; Ke, XS; Lin, B; Kalland, KH
      PloS one  8  e62547  2013

      Show Abstract
      23658742 23658742
      The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens.
      Behrens, DT; Villone, D; Koch, M; Brunner, G; Sorokin, L; Robenek, H; Bruckner-Tuderman, L; Bruckner, P; Hansen, U
      The Journal of biological chemistry  287  18700-9  2012

      Show Abstract
      22493504 22493504
      Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma.
      Kinoshita, T; Hanazawa, T; Nohata, N; Kikkawa, N; Enokida, H; Yoshino, H; Yamasaki, T; Hidaka, H; Nakagawa, M; Okamoto, Y; Seki, N
      Oncotarget  3  1386-400  2012

      Show Abstract
      23159910 23159910
      A metabolic prosurvival role for PML in breast cancer.
      Carracedo, A; Weiss, D; Leliaert, AK; Bhasin, M; de Boer, VC; Laurent, G; Adams, AC; Sundvall, M; Song, SJ; Ito, K; Finley, LS; Egia, A; Libermann, T; Gerhart-Hines, Z; Puigserver, P; Haigis, MC; Maratos-Flier, E; Richardson, AL; Schafer, ZT; Pandolfi, PP
      The Journal of clinical investigation  122  3088-100  2012

      Show Abstract
      22886304 22886304

      Related Products & Applications

      Related Products

      Catalogue Number Description  
      MAB1949 Anti-Laminin-5 Antibody, clone P3E4 Show Pricing & Availability

      Product Families

      Categories

      Life Science Research > Antibodies and Assays > Primary Antibodies